{
    "Trade/Device Name(s)": [
        "GLUCOCARD 01 Blood Glucose Monitoring System",
        "ReliOn Confirm Blood Glucose Monitoring System"
    ],
    "Submitter Information": "ARKRAY Factory, Inc.",
    "510(k) Number": "K124021",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073416"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "June 18, 2014",
    "Summary Letter Received Date": "June 19, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GLUCOCARD 01 meter",
        "ReliOn Confirm meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Control Solution",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for GLUCOCARD 01 and ReliOn Confirm blood glucose monitoring systems for quantitative measurement of glucose in capillary whole blood.",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertip or palm for single patient use at home by persons with diabetes to monitor diabetes control; not intended for diagnosis or screening or use on neonates.",
    "fda_folder": "Clinical Chemistry"
}